• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAnGes
    Picture of AnGes logo

    4563 — AnGes Share News

    ¥450.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    • Market Cap
      ¥18bn
    • Enterprise Value
      ¥18bn
    • Revenue
      ¥874m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 4563 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    4563 Dividends
    • Table: Anges -Q1 group results

      22/04/2019 07:00
    • Table: Anges -2018 parent results

      01/02/2019 06:00
    • Table: Anges -2018 group results

      01/02/2019 06:00
    • Brief: AnGes says exercise of options

      16/11/2018 06:34
    • Brief: AnGes says exercise of options

      14/11/2018 06:40
    • Brief: AnGes says exercise of options

      30/10/2018 07:04
    • Table: Anges - 9-MTH group results

      29/10/2018 06:00
    • Table: Anges -2018 group forecast

      27/08/2018 10:30
    • Brief: AnGes says exercise of options

      15/08/2018 07:10
    • Brief: AnGes says exercise of options

      31/07/2018 08:43
    • Brief: AnGes says joint development with Vasomune Therapeutics

      30/07/2018 07:53
    • Table: Anges - 6-MTH group results

      30/07/2018 07:00
    • Brief: AnGes says exercise of options

      17/07/2018 07:05
    • Brief: AnGes says exercise of options

      31/05/2018 08:12
    • Table: Anges -Q1 group results

      23/04/2018 07:00
    • Table: Anges -2017 parent results

      02/02/2018 06:00
    • Table: Anges -2017 group results

      02/02/2018 06:00
    • Table: Anges -2017 group forecast

      22/01/2018 06:00
    • Brief: AnGes submits application for marketing approval for HGF gene therapy

      22/01/2018 02:48
    • Table: Anges - 9-MTH group results

      30/10/2017 06:00
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.